Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.54 |
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27401794 | 0.98 | ALDH1A1 (0.52) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| Trifluoroacetic Acid SCHEMBL27502379 | 0.91 | ALDH1A1 (0.48) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL28504801 | 0.89 | ALDH1A1 (0.46) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL2199125 | 0.88 | MAPK1 (0.52) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL9705770 | 0.86 | MAPT (0.52) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| Hydrochloric Acid SCHEMBL11635247 | 0.86 | MAPK1 (0.50) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL11011624 | 0.85 | ALDH1A1 (0.48) | ALDH1A1HSD17B10KDM4EMAPTPOLB | |
| SCHEMBL8091454 | 0.85 | MAPT (0.55) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL11912385 | 0.85 | MAPT (0.55) | ALDH1A1HSD17B10KDM4EMAPTPKM | |
| SCHEMBL8093637 | 0.85 | MAPT (0.55) | ALDH1A1HSD17B10KDM4EMAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 667 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12480043-B2 | Red-light-mediated nucleic acid anchoring-type fluorescent probe, and preparation method therefor and use thereof | SOOCHOW UNIVERSITY (CN) | 2025-11-25 | — | — | US | claimed |
| EP-4255208-B1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-12-25 | — | — | EP | claimed |
| EP-3930472-B1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-09-11 | — | — | EP | claimed |
| CN-112868861-B | Coffee or tea extract and preparation method thereof | 内蒙古伊利实业集团股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20230407169-A1 | RED-LIGHT-MEDIATED NUCLEIC ACID ANCHORING-TYPE FLUORESCENT PROBE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SOOCHOW UNIVERSITY (CN) | 2023-12-21 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-115998908-A | Diagnosis and treatment integrated nucleic acid anchored fluorescent probe and preparation method and application thereof | 苏州大学 | 2023-04-25 | — | — | CN | claimed |
| CN-112592386-B | Red light mediated nucleic acid anchoring type fluorescent probe and preparation method and application thereof | 苏州大学 | 2022-04-15 | — | — | CN | claimed |
| CN-112592386-A | Red light mediated nucleic acid anchoring type fluorescent probe and preparation method and application thereof | 苏州大学 | 2021-04-02 | — | — | CN | claimed |
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| US-5977169-A | FOR TREATMENT OF A PERSON WITH AIDS OR AIDS RELATED DISEASES | PHARMACIA & UPJOHN COMPANY | 1999-11-02 | — | — | US | claimed |
| EP-0720607-A1 | SUBSTITUTED TETRONIC ACIDS USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | PHARMACIA & UPJOHN COMPANY (US) | 1996-07-10 | — | — | EP | claimed |
| EP-0691953-A1 | 1-AMIDINOPHENYL-PYRROLIDONES PIPERIDINONES AZETINONES AS PLATELET AGGREGATION INHIBITORS | G.D. SEARLE & CO. (US) | 1996-01-17 | — | — | EP | claimed |
| EP-0471833-B1 | METHOD FOR INCREASING THE ALPHA TO BETA RATIO IN AN ASPARTAME COUPLING REACTION | NUTRASWEET CO (US) | 1995-06-14 | — | — | EP | claimed |
| WO-1995007901-A1 | SUBSTITUTED TETRONIC ACIDS USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1994022820-A1 | 1-AMIDINOPHENYL-PYRROLIDONES PIPERIDINONES AZETINONES AS PLATELET AGGREGATION INHIBITORS | G.D. SEARLE & CO. (US) | 1994-10-13 | — | — | WO | claimed |
| EP-0447967-B1 | Gelation of acrylamide-containing polymers with furfuryl alcohol and water dispersible aldehydes | PHILLIPS PETROLEUM CO (US) | 1994-05-18 | — | — | EP | claimed |
| EP-0304478-B1 | PROCESS FOR NITROGEN OXIDES REDUCTION WITH MINIMIZATION OF THE PRODUCTION OF OTHER POLLUTANTS | FUEL TECH, INC. (US) | 1993-06-23 | — | — | EP | claimed |
| EP-0354220-B1 | MULTI-STAGE PROCESS FOR REDUCING THE CONCENTRATION OF POLLUTANTS IN AN EFFLUENT | FUEL TECH, INC. (US) | 1993-04-21 | — | — | EP | claimed |
| EP-0389617-B1 | TREATMENT OF RHODIUM CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1993-03-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12480043-B2 | Red-light-mediated nucleic acid anchoring-type fluorescent probe, and preparation method therefor and use thereof | CPSF7, CPSF1, WASF2 | ALDH1A1 1419/4885HSD17B10 2065/4885KDM4E 3501/4885 |
| US-20230407169-A1 | RED-LIGHT-MEDIATED NUCLEIC ACID ANCHORING-TYPE FLUORESCENT PROBE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CPSF7, CPSF1, WASF2 | ALDH1A1 1419/4885HSD17B10 2065/4885KDM4E 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.